Search 

CTTQ is a leading big pharma with integrated R&D, manufacturing, marketing, and sales in China. We are the markter leader in drugs treating liver disease and cancer in China. CTTQ is a subsidiary of Sino Biopharmaceutical Ltd., which has been listed on Hong Kong Stock Exchange since 2003. Currently CTTQ has more than 10,000 employees, with total revenue of RMB 23 billion (USD$3.2 B) in 2019.

We are looking for cooperation opportunities with pharma/biotech companies via licensing and R & D collaboration in the following areas: Innovative small molecule and biologics products in therapeutic areas of oncology, liver, infectious, respiratory, cardiovascular, and metabolic diseases, etc.

Founded in May 1989, China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) is the national indUnited Statestrial association in China devoted to promote international trade and investment in the healthcare sector.

CCCMHPIE has a diverse membership including the major R&D facilities, manufactures, trading companies and investment institutions in China, ranging from pharmaceuticals, medical devices and equipment, biopharmaceuticals, traditional Chinese medicines, nutraceuticals, functional cosmetics to foods for special medical purposes. It is a professional trade and investment promotion organization in the Chinese healthcare sector while serving as the bridge between authorities and enterprises as well as Chinese and foreign partners.

A leading national pharmaceutical company in China

Stated-owned large pharmaceutical corporation, covering R&D, manufacture, and sales of chemical and biological medicine.

We are the flagship subsidiary of China Resources Group, engaging in the research and development, manufacturing, distribution and retail of a broad range of pharmaceutical and healthcare products.In 2018, our total revenue is HK$ 189.7 billion.
Currently CR Pharma Group is one of the TOP 3 pharmacetucial group in China, and our core competences is capabilities are marketing&sales(3000+ Sales Reps for RX and 3000+ Sales Reps for OTC and healthcare products, local Regulatory Affairs(Dedicated RA team), and great manufacturing facilities(40+ manufacturing sites in China, including API and finished products of all dosage forms, 4 sites are approved by US FDA and EMEA).
As a listed company in HK, CR Pharma has estalished consodiated business reputation in healtcare industry and capital market. And currently, nearly all top 50 MNC pharmacetical companies are our business partner in China, and business scope includes JV, Licensing, Commercial Distribution.

a large hospital

Convalife is an innovative, research-based, clinical stage biopharmaceutical company focused on bringing innovative therapies to patients with cancer, autoimmune and infectious diseases in China and around the world.

Big pharm in China